The Pasteur Network convened its Ordinary General Assembly on June 26, 2026, at the Sciensano Center in Brussels, marking the first annual meeting fully aligned with the French institutional calendar. The hybrid session brought together members from Africa, the Americas, Asia-Pacific, and the Europe-Mediterranean region. The executive director presented a comprehensive activity report highlighting significant strategic advancements.

 In January 2026, the Network achieved full membership in the WHO's Global Outbreak Alert and Response Network (GOARN) and, by June, had compiled a roster of deployable experts in this regard. The regional health observatory accelerator entered its second phase, and the DURABLE project within the Network expanded its educational activities globally. Vaccine innovation efforts advanced with a focus on greener production methods, while four projects received funding under the "Grand Challenges and 100-Day Mission" program. Moreover, the Network signed agreements with the Pan American Health Organization (PAHO), expanded its scientific working groups to nine active groups with over 100 participants, and increased registered users on the PN platform to more than 2,000. Regional registration was completed in Senegal, with similar efforts underway in Hong Kong and Brazil. The Board also discussed the Network's role in responding to the Marburg virus outbreak through the capabilities of the Pasteur Institute of Dakar. Following the management report, members approved the upcoming Strategic Advisory Board meeting in Rio. An audit report was presented confirming compliance with new accounting standards effective January 2025. The Assembly approved the 2025 financial accounts and the allocation of financial results, including the creation of a reserve for the "Spark Project" to ensure program continuity, and formally discharged the Board of Directors for its 2025 responsibilities.

 The Assembly concluded with two membership resolutions decided via digital anonymous voting. The first, transferring Network membership from the Armand-Frappier Health Biotechnology Center to the INRS (Institut national de la recherche scientifique) in Quebec, Canada, passed with 27 votes in favor, one against, and one abstention. The second, admitting the Université de Montréal's Faculty of Medicine as the Network's first affiliated member under the new governance framework, passed with 25 votes in favor, two against, and two abstentions.